Current Report · Items 5.07 · 8-K
Profusa, Inc.
PFSANASDAQEQUITYCurrent
Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders. On September 18, 2026, the Company held a Special Meeting of Stockholders (the “Meeting”), which was convened virtually at www.virtualshareholdermeeting.com/PFSA2026SM, pursuant to notice duly given.…
Filed Sep 21, 2026Accepted Sep 18, 2026, 8:23 PM EDTCIK 1859807Accession 0001213900-26-101568
Company context
Profusa was incorporated in the state of California on May 11, 2009 and operates as a digital health technology company based in Berkeley, California. The Company is engaged in the development of a new generation of biointegrated sensors that potentially empowers the individual with the ability to monitor their unique body chemistry. Profusa has invested over the last twelve years more than $100 million from sophisticated venture investors as well as the most sophisticated research institutions in the U.S. (including approximately $30 million from Defense Advance Research Projects Agency (“DARPA”) and the National Institutes of Health (“NIH”)) to develop a unique biosensor platform that is easily injected subcutaneously to provide, for the first time, real-time, individual biochemistry, that is cost effective while functioning for more than six times longer than known best in class solutions on the market today.
Current securities
Historical securities (4)
Registered securities in this filing
PROFUSA, INC. · 8-K · Filed 2026-09-21
As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.
Common Stock, par value $0.0001 per share
- Exchange
- NASDAQ
- Classification
- COMMON
- Status
- Current
Filing context
Context: AsOf2026-09-18
Dimensions: Not supplied
Accession 000121390026101568 · 1 registered-security cover member
Read the exact SEC filing ↗Disclosure sections
Items 5.07Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 5.07Item 5.07 - Submission of Matters to Vote
Item 5.07 Submission of Matters to a Vote of Security Holders.
On September 18, 2026, the Company held a Special
Meeting of Stockholders (the “Meeting”), which was convened virtually at www.virtualshareholdermeeting.com/PFSA2026SM,
pursuant to notice duly given. Definitive proxy materials relating to the Meeting were filed with the Securities and Exchange Commission
on August 28, 2026, and were transmitted to all stockholders that held of record as of August 19, 2026 (the “Record Date”).
As of the close of business on the Record Date, there were 605,647 shares of the Company’s common stock outstanding, each share being
entitled to one vote. At the Meeting, the holders of 287,890 shares of the Company’s common stock were represented in person or by proxy,
constituting a quorum.
The stockholders were asked to approve an amendment
to the Company’s Amended and Restated Certificate of Incorporation, as amended, to, at the discretion of the Company’s Board
of Directors, effect one or more reverse stock splits over the course of the next two years of the Company’s issued and outstanding
common stock, at a ratio of 1-for-2 to 1-for-12, provided that the aggregate splits will not exceed a ratio of 1-for-12, with the exact
ratio within such range to be determined at the discretion of the Company’s Board of Directors (or any of its delegated authorized
persons) at its or their discretion without further approval or authorization of the Company’s stockholders (the “Reverse
Stock Split Proposal”). The vote was as follows:
FOR AGAINST ABSTAIN BROKER NON-VOTES
───────────────────────────────────────────────────────────
262,920 17,360 7,610 0
The stockholders were also asked to authorize
an adjournment or adjournments of the Meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies if
there are not sufficient votes in favor of the Reverse Stock Split Proposal. The vote was as follows:
FOR AGAINST ABSTAIN BROKER NON-VOTES
───────────────────────────────────────────────────────────
264,664 15,328 7,898 0
No other actions were taken at the meeting.
Exhibit No. Description of Exhibit
────────────────────────────────────────────────────────────────────────────────────────────────
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)